Sodium Phosphate Sprint Performance Randomized Trial: What the Evidence Says

Quick Answer

Sodium Phosphate Sprint Performance Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• This review excluded supplements where the proposed ergogenic mechanism did not involve failure at high intensity; studies with primarily clinical evidence and not focused on sports performance; or when available evidence did not support a clear mechanistic link with the framework. [Stout Jeffrey R. (2026); evidence level 3]
• The review did not perform risk-of-bias assessments or grading of evidence, nor did it pool data using meta-analysis; therefore, any conclusions drawn should be regarded as hypothesis-generating rather than exhaustive. [Stout Jeffrey R. (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For sodium phosphate sprint performance randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Liang Weibao (2026). No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials. DOI: 10.3389/fnut.2026.1818755. PMCID: PMC13061858. PMID: 41971372. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13061858/
• Stout Jeffrey R. (2026). Delaying task failure in high-intensity exercise: a Pi-afferent-effort framework for targeted sports nutrition. DOI: 10.1080/15502783.2026.2711031. PMCID: PMC13425531. PMID: 42530633. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13425531/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.